AnPac Bio-Medical Science Co Ltd - ADR

NASDAQ:ANPC   1:41:04 PM EDT
0.27
0.00 (-0.95%)
Earnings Announcements

AnPac Bio Reports 49.1% Decrease In Net Loss In First Quarter Of Fiscal 2022

Published: 05/31/2022 21:13 GMT
AnPac Bio-Medical Science Co Ltd - ADR (ANPC) - Anpac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022.
Q1 Revenue Fell 9.9 Percent to Rmb 2.0 Million.
Basic and Diluted Loss per Share Was Rmb0.85 (us$0.13) for Q1 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.